| INDRAYANI BIOTECH  Back to All Ratios | 
INDRAYANI BIOTECH Last 5 Year Working Capital/Sales History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Working Capital/Sales(x) | 2.87 | 29.03 | -108.21 | -7.94 | 9.05 | 
What is the latest Working Capital/Sales ratio of INDRAYANI BIOTECH ?
| Year | Working Capital/Sales | 
|---|---|
| Mar2024 | 2.87 | 
| Mar2023 | 29.03 | 
| Mar2022 | -108.21 | 
| Mar2021 | -7.94 | 
| Mar2020 | 9.05 | 
How is Working Capital/Sales of INDRAYANI BIOTECH Trending?
| Years | Working Capital/Sales | % Change | |
|---|---|---|---|
| Mar2024 | 2.87 | -90.11 | |
| Mar2023 | 29.03 | Positive | |
| Mar2022 | -108.21 | Negative | |
| Mar2021 | -7.94 | Negative | |
| Mar2020 | 9.05 | - | |
Other Financial Ratios of INDRAYANI BIOTECH
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap | 
Compare Working Capital/Sales ratio of peers of INDRAYANI BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDRAYANI BIOTECH | ₹64.2 Cr | 0.5% | 14.2% | -62.1% | Stock Analytics | |
| No other companies found in this Industry | ||||||
INDRAYANI BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| INDRAYANI BIOTECH | 0.5% | 14.2% | -62.1% | 
| SENSEX | -0.3% | 4.5% | 5.7% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    